HALL LAURIE J TRUSTEE - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 232 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2021. The put-call ratio across all filers is 8.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
HALL LAURIE J TRUSTEE ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q4 2022$2
-99.9%
40
-33.3%
0.00%0.0%
Q3 2022$2,000
-60.0%
60
-33.3%
0.00%
-50.0%
Q2 2022$5,000
-28.6%
900.0%0.00%
-33.3%
Q1 2022$7,000
-12.5%
900.0%0.00%0.0%
Q4 2021$8,0000.0%900.0%0.00%0.0%
Q3 2021$8,000
-38.5%
90
-35.7%
0.00%
-40.0%
Q2 2021$13,000
-18.8%
1400.0%0.01%
-16.7%
Q1 2021$16,000
-15.8%
1400.0%0.01%
-25.0%
Q4 2020$19,000
+58.3%
1400.0%0.01%
+60.0%
Q3 2020$12,000
+200.0%
140
+40.0%
0.01%
+150.0%
Q4 2019$4,0001000.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q4 2021
NameSharesValueWeighting ↓
Iguana Healthcare Management, LLC 75,000$5,084,0002.52%
COLUMBIA WANGER ASSET MANAGEMENT LLC 1,237,825$83,900,0001.18%
CAPITAL INTERNATIONAL LTD /CA/ 206,718$14,011,0000.91%
Cormorant Asset Management, LP 75,000$5,084,0000.74%
Capital International Sarl 107,450$7,283,0000.63%
Rock Springs Capital Management LP 159,750$10,828,0000.62%
Opus Point Partners Management, LLC 12,201$827,0000.61%
Hood River Capital Management LLC 109,629$7,431,0000.56%
Aureus Asset Management, LLC 50,740$2,927,0000.51%
ROCKEFELLER FINANCIAL SERVICES INC 374,663$25,395,0000.51%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders